Cargando…

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service

BACKGROUND: Deintensification and less drug regimen (LDR) antiretroviral therapy (ART) strategies have proved to be effective in terms of maintaining viral suppression in human immunodeficiency virus (HIV)-positive patients, increasing tolerability, and reducing toxicity of antiretroviral drugs admi...

Descripción completa

Detalles Bibliográficos
Autores principales: Restelli, Umberto, Andreoni, Massimo, Antinori, Andrea, Bonfanti, Marzia, Di Perri, Giovanni, Galli, Massimo, Lazzarin, Adriano, Rizzardini, Giuliano, Croce, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181445/
https://www.ncbi.nlm.nih.gov/pubmed/25285019
http://dx.doi.org/10.2147/CEOR.S68101
_version_ 1782337373450797056
author Restelli, Umberto
Andreoni, Massimo
Antinori, Andrea
Bonfanti, Marzia
Di Perri, Giovanni
Galli, Massimo
Lazzarin, Adriano
Rizzardini, Giuliano
Croce, Davide
author_facet Restelli, Umberto
Andreoni, Massimo
Antinori, Andrea
Bonfanti, Marzia
Di Perri, Giovanni
Galli, Massimo
Lazzarin, Adriano
Rizzardini, Giuliano
Croce, Davide
author_sort Restelli, Umberto
collection PubMed
description BACKGROUND: Deintensification and less drug regimen (LDR) antiretroviral therapy (ART) strategies have proved to be effective in terms of maintaining viral suppression in human immunodeficiency virus (HIV)-positive patients, increasing tolerability, and reducing toxicity of antiretroviral drugs administered to patients. However, the economic impact of these strategies have not been widely investigated. The aim of the study is to evaluate the economic impact that ART LDR could have on the Italian National Health Service (INHS) budget. METHODS: A budget impact model was structured to assess the potential savings for the INHS by the use of ART LDR for HIV-positive patients with a 3 year perspective. Data concerning ART cost, patient distribution within different ARTs, and probabilities for patients to change ART on a yearly basis were collected within four Italian infectious diseases departments, providing ART to 13.7% of the total number of patients receiving ART in Italy. RESULTS: The LDR investigated (protease inhibitor-based dual and monotherapies) led to savings for the hospitals involved when compared to the “do nothing” scenario on a 3 year basis, between 6.7% (23.11 million €) and 12.8% (44.32 million €) of the total ART expenditures. The mean yearly cost per patient is reduced from 9,875 € in the do nothing scenario to a range between 9,218 € and 8,615 €. The use of these strategies within the four departments involved would have led to a reduction of ART expenditures for the INHS of between 1.1% and 2.1% in 3 years. CONCLUSION: ART LDR simplification would have a significant impact in the reduction of ART-related costs within the hospitals involved in the study. These strategies could therefore be addressed as a sustainable answer to the public financing reduction observed within the INHS in the last year, allowing therapies to be dispensed without affecting the quality of the services provided.
format Online
Article
Text
id pubmed-4181445
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-41814452014-10-03 Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service Restelli, Umberto Andreoni, Massimo Antinori, Andrea Bonfanti, Marzia Di Perri, Giovanni Galli, Massimo Lazzarin, Adriano Rizzardini, Giuliano Croce, Davide Clinicoecon Outcomes Res Original Research BACKGROUND: Deintensification and less drug regimen (LDR) antiretroviral therapy (ART) strategies have proved to be effective in terms of maintaining viral suppression in human immunodeficiency virus (HIV)-positive patients, increasing tolerability, and reducing toxicity of antiretroviral drugs administered to patients. However, the economic impact of these strategies have not been widely investigated. The aim of the study is to evaluate the economic impact that ART LDR could have on the Italian National Health Service (INHS) budget. METHODS: A budget impact model was structured to assess the potential savings for the INHS by the use of ART LDR for HIV-positive patients with a 3 year perspective. Data concerning ART cost, patient distribution within different ARTs, and probabilities for patients to change ART on a yearly basis were collected within four Italian infectious diseases departments, providing ART to 13.7% of the total number of patients receiving ART in Italy. RESULTS: The LDR investigated (protease inhibitor-based dual and monotherapies) led to savings for the hospitals involved when compared to the “do nothing” scenario on a 3 year basis, between 6.7% (23.11 million €) and 12.8% (44.32 million €) of the total ART expenditures. The mean yearly cost per patient is reduced from 9,875 € in the do nothing scenario to a range between 9,218 € and 8,615 €. The use of these strategies within the four departments involved would have led to a reduction of ART expenditures for the INHS of between 1.1% and 2.1% in 3 years. CONCLUSION: ART LDR simplification would have a significant impact in the reduction of ART-related costs within the hospitals involved in the study. These strategies could therefore be addressed as a sustainable answer to the public financing reduction observed within the INHS in the last year, allowing therapies to be dispensed without affecting the quality of the services provided. Dove Medical Press 2014-09-23 /pmc/articles/PMC4181445/ /pubmed/25285019 http://dx.doi.org/10.2147/CEOR.S68101 Text en © 2014 Restelli et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Restelli, Umberto
Andreoni, Massimo
Antinori, Andrea
Bonfanti, Marzia
Di Perri, Giovanni
Galli, Massimo
Lazzarin, Adriano
Rizzardini, Giuliano
Croce, Davide
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
title Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
title_full Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
title_fullStr Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
title_full_unstemmed Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
title_short Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
title_sort budget impact analysis of antiretroviral less drug regimen simplification in hiv-positive patients on the italian national health service
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181445/
https://www.ncbi.nlm.nih.gov/pubmed/25285019
http://dx.doi.org/10.2147/CEOR.S68101
work_keys_str_mv AT restelliumberto budgetimpactanalysisofantiretrovirallessdrugregimensimplificationinhivpositivepatientsontheitaliannationalhealthservice
AT andreonimassimo budgetimpactanalysisofantiretrovirallessdrugregimensimplificationinhivpositivepatientsontheitaliannationalhealthservice
AT antinoriandrea budgetimpactanalysisofantiretrovirallessdrugregimensimplificationinhivpositivepatientsontheitaliannationalhealthservice
AT bonfantimarzia budgetimpactanalysisofantiretrovirallessdrugregimensimplificationinhivpositivepatientsontheitaliannationalhealthservice
AT diperrigiovanni budgetimpactanalysisofantiretrovirallessdrugregimensimplificationinhivpositivepatientsontheitaliannationalhealthservice
AT gallimassimo budgetimpactanalysisofantiretrovirallessdrugregimensimplificationinhivpositivepatientsontheitaliannationalhealthservice
AT lazzarinadriano budgetimpactanalysisofantiretrovirallessdrugregimensimplificationinhivpositivepatientsontheitaliannationalhealthservice
AT rizzardinigiuliano budgetimpactanalysisofantiretrovirallessdrugregimensimplificationinhivpositivepatientsontheitaliannationalhealthservice
AT crocedavide budgetimpactanalysisofantiretrovirallessdrugregimensimplificationinhivpositivepatientsontheitaliannationalhealthservice